Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-006012
Filing Date
2025-04-30
Accepted
2025-04-30 16:31:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20250428xdefa14a.htm DEFA14A 14427
2 GRAPHIC tmb-20250428xdefa14a_bg001.jpg GRAPHIC 160224
3 GRAPHIC tmb-20250428xdefa14a_bg002.jpg GRAPHIC 103532
  Complete submission text file 0001558370-25-006012.txt   371328
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35969 | Film No.: 25895973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)